Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sensorion SA
RFMCurrent price
0.69 EUR
+0.016 EUR (+2.39%)
Last closed
0.7 EUR
Company
www.sensorion.com
ISIN
FR0012596468
Sector
Healthcare
Industry
Biotechnology
Exchange
Stuttgart Exchange
Capitalization
210 915 713 EUR
Yield for 12 month
+27.72 %
1Y
3Y
5Y
10Y
15Y
RFM
Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. Its pipeline includes various products in the development stage for restoring, treating, and preventing inner ear related disorders. The company's product portfolio includes SENS-401 SSNHL, which has completed Phase 2 clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2 clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, which is in Phase 2 clinical trial for the treatment of hearing preservation after cochlear implantation. It is also developing OTOF-GT (SENS-501), a gene therapy development program that has completed Phase 1 clinical trial to restore hearing in people living with Otoferlin deficiency; and GJB2-GT, a gene therapy development program, which is in pre-clinical trial to restore hearing in people living with hearing loss due to mutations in the GJB2 gene. The company was incorporated in 2009 and is headquartered in Montpellier, France. Address: 375, rue du Professeur Joseph Blayac, Montpellier, France, 34080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.76 EURP/E ratio
–Dividend Yield
–Current Year
+4 789 161 EUR
Last Year
+4 981 603 EUR
Current Quarter
+3 165 468 EUR
Last Quarter
+3 040 430 EUR
Current Year
+3 824 676 EUR
Last Year
+4 203 635 EUR
Current Quarter
+2 590 939 EUR
Last Quarter
+2 557 062 EUR
Key Figures RFM
1 year
3 years
5 years
10 years
EBITDA
-24 311 814 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.67 %
PEG Ratio
–
Return On Equity TTM
-50.73 %
Wall Street Target Price
1.76 EUR
Revenue TTM
6 205 935 EUR
Book Value
0.28 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
22.7 %
Dividend Yield
–
Gross Profit TTM
5 054 162 EUR
Earnings per share
-0.071 EUR
Diluted Eps TTM
-0.071 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RFM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RFM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RFM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
23.4039
Price Sales TTM
33.9861
Enterprise Value EBITDA
-7.7049
Price Book MRQ
2.5172
Financials RFM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RFM
For 52 weeks
0.41 EUR
1.05 EUR
50 Day MA
0.77 EUR
Shares Short Prior Month
–
200 Day MA
0.74 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart